361 related articles for article (PubMed ID: 11922730)
21. [Examination of the mediastinum in staging of primary bronchial carcinoma].
Rooyackers JM; Roukema JA; Aarts NJ; Palmen FM
Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1145-9. PubMed ID: 2192290
[TBL] [Abstract][Full Text] [Related]
22. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ
Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
[TBL] [Abstract][Full Text] [Related]
23. Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation.
Gross BH; Brown RK; Kalemkerian GP
Lung Cancer; 2011 Jul; 73(1):59-62. PubMed ID: 21094559
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of positron emission tomography for non-small cell lung carcinoma in Canada.
Sloka JS; Hollett PD; Mathews M
Med Sci Monit; 2004 May; 10(5):MT73-80. PubMed ID: 15114279
[TBL] [Abstract][Full Text] [Related]
25. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma.
Patterson GA; Ginsberg RJ; Poon PY; Cooper JD; Goldberg M; Jones D; Pearson FG; Todd TR; Waters P; Bull S
J Thorac Cardiovasc Surg; 1987 Nov; 94(5):679-84. PubMed ID: 3669696
[TBL] [Abstract][Full Text] [Related]
26. Preoperative CT examination for staging of mediastinal lymph-nodes in patients with (operable) non-small cell lung cancer.
Verschakelen J; Deneffe G; Baert AL
Rontgenblatter; 1988 Mar; 41(3):106-7. PubMed ID: 2838890
[TBL] [Abstract][Full Text] [Related]
27. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Guhlmann A; Storck M; Kotzerke J; Moog F; Sunder-Plassmann L; Reske SN
Thorax; 1997 May; 52(5):438-41. PubMed ID: 9176535
[TBL] [Abstract][Full Text] [Related]
28. [Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
Bury T; Corhay JL; Paulus P; Weber T; D'Harcour JB; Limet R; Rigo P; Radermecker MF
Rev Mal Respir; 1996 Jul; 13(3):281-6. PubMed ID: 8765921
[TBL] [Abstract][Full Text] [Related]
29. Extended cervical mediastinoscopy: mature results of a clinical protocol for staging bronchogenic carcinoma of the left lung.
Obiols C; Call S; Rami-Porta R; Iglesias M; Saumench R; Serra-Mitjans M; Gonzalez-Pont G; Belda J
Eur J Cardiothorac Surg; 2012 May; 41(5):1043-6. PubMed ID: 22219461
[TBL] [Abstract][Full Text] [Related]
30. [Strategy for staging non-small cell bronchial carcinoma (NSCLC) with special reference to imaging procedures].
Gückel C; Stulz P; Bolliger CT
Aktuelle Radiol; 1995 Mar; 5(2):79-86. PubMed ID: 7756366
[TBL] [Abstract][Full Text] [Related]
31. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.
Lee BE; von Haag D; Lown T; Lau D; Calhoun R; Follette D
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):746-52. PubMed ID: 17320577
[TBL] [Abstract][Full Text] [Related]
32. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W
Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
[TBL] [Abstract][Full Text] [Related]
33. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
[TBL] [Abstract][Full Text] [Related]
34. Mediastinal staging of lung cancer: the changing role of mediastinoscopy.
Weissberg D
Isr J Med Sci; 1995; 31(2-3):122-4. PubMed ID: 7744580
[TBL] [Abstract][Full Text] [Related]
35. Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer.
Sanli M; Isik AF; Zincirkeser S; Elbek O; Mete A; Tuncozgur B; Elbeyli L
J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1200-5. PubMed ID: 19660381
[TBL] [Abstract][Full Text] [Related]
36. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
37. Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer.
Kramer H; Groen HJ
Ann Surg; 2003 Aug; 238(2):180-8. PubMed ID: 12894010
[TBL] [Abstract][Full Text] [Related]
38. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V
Clin Lung Cancer; 2008 Jan; 9(1):39-43. PubMed ID: 18282357
[TBL] [Abstract][Full Text] [Related]
39. Incremental value of PET/CT Over CT for mediastinal nodal staging of non-small cell lung cancer: Comparison between patients with and without idiopathic pulmonary fibrosis.
Jeon TY; Lee KS; Yi CA; Chung MP; Kwon OJ; Kim BT; Shim YM
AJR Am J Roentgenol; 2010 Aug; 195(2):370-6. PubMed ID: 20651192
[TBL] [Abstract][Full Text] [Related]
40. Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.
Aquino SL; Asmuth JC; Alpert NM; Halpern EF; Fischman AJ
J Comput Assist Tomogr; 2003; 27(4):479-84. PubMed ID: 12886128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
